Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica

Journal of Infectious Diseases

Volumn 194, Issue 5, 2006, Pages 552-560

  Maloney, Elizabeth Margaret ^a,e,i   Yamamo, Yoshihisa ^b,f   VanVeldhuisen, Paul C ^a,c   Sawada, Takashi ^g   Kim, Norma ^d   Cranston, Beverley ^h   Hanchard, Barrie ^h   Jacobson, Steven ^b   Hisada, Michie ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c EMMES CORPORATION   (United States)

^d RTI INTERNATIONAL   (United States)

^e NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^f Kagoshima City Hospital   (Japan)

^g Clinical Research Center   (Japan)

^h UNIVERSITY OF THE WEST INDIES   (Jamaica)

ⁱ CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; TAX PROTEIN; VIRUS DNA;

ADULT; ANTIBODY TITER; ARTICLE; CALCULATION; DISEASE COURSE; DISEASE MARKER; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; INFANT; INFECTION RISK; JAMAICA; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROVIRUS; VIRUS INFECTION; VIRUS LOAD;

BREAST FEEDING; CHILD; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; HTLV-I ANTIBODIES; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; INFANT; INFANT, NEWBORN; JAMAICA; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL CARE; VIRAL LOAD;

EID: 33748084720     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/506365     Document Type: Article

References (35)

1. Takatsuki K, Uchiyama T, Sagawa K, Yodoi J. Adult T-cell leukemia in Japan. In: Setno S, Takaku F, eds: Topics in hematology. Amsterdam: Excerpta Medica, 1977:73.
2. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet 1985; 2:407-10.
3. Mochizuki M, Watanabe T, Yamaguchi K, et al. Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologie studies. J Infect Dis 1992; 166:943-4.
4. Nishioka K, Maruyama I, Sato K, Kitajima I, Nakajima Y, Osame M. Chronic inflammatory arthropathy associated with HTLV-I. Lancet 1989; 1:441.
5. Morgan OS, Rodgers-Johnson P, Mora C, Char G. HTLV-1 and polymyositis in Jamaica. Lancet 1989; 2:1184-7.
6. Kawai H, Inui T, Kashiwagi S, et al. HTLV-I infection in patients with autoimmune thyroiditis (Hashimoto's thyroiditis). J Med Virol 1992; 38:138-41.
7. Terada K, Katamine S, Eguchi K, et al. Prevalence of serum and salivary antibodies to HTLV-I in Sjōgren's syndrome. Lancet 1994; 344:1116-9.
8. LaGrenade L, Hanchard B, Fletcher V, Cranston B, Blattner WA. Infective dermatitis of Jamaican children: a marker for HTLV-I infection. Lancet 1990; 336:1345-7.
9. Hanchard B, LaGrenade L, Carberry C, et al. Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years. Lancet 1991; 338:1593-4.
10. LaGrenade L, Sonoda S, Miller W, et al. HLA DRB1*DQB1* haplotype in HTLV-I-associated familial infective dermatitis may predict development of HTLV-I-associated myelopathy/tropical spastic paraparesis. Am J Med Genet 1996; 61:37-41.
11. LaGrenade L, Morgan OSC, Carberry C, et al. Tropical spastic paraparesis occurring in HTLV-I associated infective dermatitis: report of two cases. West Indian Med J 1995; 44:34-5.
12. Pombo de Olivdra MS, Dobbin JA, Loureiro P, et al. Genetic mutation and early onset of T-cell leukemia in pediatric patients infected at birth with HTLV-I. Leuk Res 2002;26:155-61.
13. Araujo APOC, Fontenelle LMC, Padua PAB, Filho HSM, Araujo AdQC. Juvenile human T lymphotropic virus type I-associated myelopathy. Clin Infect Dis 2002; 35:201-4.
14. Nagai M, Usuku K, Matsumoto W, et al. Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high provirus load strongly predisposes to HAM/TSP. J Neurovirol 1998; 4:586-93.
15. Okayama A, Stuver SO, Matsuoka M, et al. Role of HTLV-1 proviral DNA load and clonality in the development of adult T-cell leukemia/lymphoma in asymptomatic carriers. Int J Cancer 2004; 110:621-5.
16. Chen YM, Chen SH, Fu CY, Chen JY, Osame M. Antibody reactivities to tumor suppressor protein p53 and HTLV-I Tof, Rex and Tax in HTLV-I-infected people with differing clinical status. Int J Cancer 1997; 71:196-202.
17. Shinzato O, Kamihara S, Ikeda S, et al. Relationship between the anti-HTLV-I antibody level, the number of abnormal lymphocytes and the viral-genome dose in HTLV-I-infected individuals. Int J Cancer 1993; 54:208-12.
18. Hisada M, Okayama A, Shioriri S, Spiegelman DL, Stuver SO, Mueller NE. Risk factors for adult T-cell leukemia among carriers of human T lymphotropic virus type I. Blood 1998;92:3557-61.
19. Bartholomew C, Jack N, Edwards J, et al. HTLV-I serostatus of mothers of patients with adult T-cell leukemia and HTLV-I-associated myelopathy/tropical spastic paraparesis. J Hum Virol 1998; 1:302-5.
20. Wiktor SZ, Pate EJ, Rosenberg PS, et al. Mother-to-child transmission of human T-cell lymphotropic virus type I is associated with prolonged breast-feeding. J Hum Virol 1997; 1:37-44.
21. tax antibody-positive mothers. Jpn J Cancer Res 1989; 80:506-8.
22. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986; 73:13-2225.
23. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. JASA 1979; 74:829-36.
24. Maloney EM, Hisada M, Palmer P, et al. Human T cell lymphotropic virus type I-associated infective dermatitis in Jamaica: a case report of clinical and biologic correlates. Pediatr Infect Dis J 2000; 19:560-5.
25. Manns A, Miley WJ, Wilks RJ, et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-1 infection. J Infect Dis 1999; 180:1487-93.
26. Hisada M, Stuver SO, Okayama A, et al. Persistent paradox of natural history of human T lymphotropic virus type I: parallel analyses of Japanese and Jamaican carriers. J Infect Dis 2004; 190:1605-9.
27. Okayama A, Stuver S, Iga M, et al. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. J Infect Dis 2001; 183:1031-7.
28. + T cells in cerebrospinal fluid from patients with HAM/TSP. Ann Neurol 2001; 50:807-12.
29. van der Zwet WC, Vandenbroucke-Grauls CMJE, van Elburg RM, Cranendonk A, Zaaijer HL. Neonatal antibody titers against varicella-zoster virus in relation to gestational age, birth weight, and maternal titer. Pediatrics 2002; 109:79-85.
30. Linder N, Taushtein I, Handshert R, et al. Placental transfer of maternal poliovirus antibodies in full-term and pre-term infants. Vaccine 1998; 16:236-9.
31. Under N, Sirota L, Aboudy Y, et al. Placental transfer of maternal rubella antibodies to full-term and preterm infants. Infection 1999; 27:203-7.
32. Mortreux F, Leclercq I, Gabet AS, et al. Somatic mutation in human T-cell leukemia virus type 1 provirus and flanking cellular sequences during clonal expansion in vivo. J Natl Cancer Inst 2001; 93:367-77.
33. Bangham CR. The immune response to HTLV-I. Curr Opin Immunol 2000; 12:397-402.
34. Gabet AS, Kazanji M, Couppie P, et al. Adult T-cell leukaemia/lymphoma- like human T-cell leukaemia virus-1 replication in infective dermatitis. Br J Haematol 2003; 123:406-12.
35. Maloney EM, Nagai M, Hisada M, et al. Prediagnostic human T lymphotropic virus type I provirus loads were highest in Jamaican children who developed seborrheic dermatitis and severe anemia. J Infect Dis 2004; 189:41-5.